ORBIMED ADVISORS LLC 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:18 pm Sale | 2025-12-31 | 13G | C4 THERAPEUTICS INC CCCC | ORBIMED ADVISORS LLC | 883,534 1.000% | -2,684,812 (-75.24%) | Filing |
| 2025-11-14 6:08 pm Sale | 2025-09-30 | 13G | C4 THERAPEUTICS INC CCCC | ORBIMED ADVISORS LLC | 3,568,346 5.000% | -1,087,254 (-23.35%) | Filing |
| 2025-05-15 8:09 pm Purchase | 2025-03-31 | 13G | C4 THERAPEUTICS INC CCCC | ORBIMED ADVISORS LLC | 4,655,600 6.600% | 1,729,700 (+59.12%) | Filing |